Autolus Therapeutics Ltd | AUTL - Ebit

Prix De L'Action
1.21
Variation Quotidienne
-0.08 -6.20%
Mensuellement
-27.54%
Annuel
-27.11%
Q1 Prévisions
1.30




Ebit Changement Date
AstraZeneca USD 2.97B 4.48B 2025-12
Autolus Therapeutics Ltd USD -72.47M 845K 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Novartis USD 4.06B 530M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Silence Therapeutics USD -12.46M 13.78M 2025-12